8307 — Medicskin Holdings Cashflow Statement
0.000.00%
Last trade - 00:00- HK$55.54m
- HK$56.38m
- HK$47.87m
Annual cashflow statement for Medicskin Holdings, fiscal year end - March 31st, HKD millions except per share, conversion factor applied.
C2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 4.42 | -3.03 | -3.12 | -3.46 | 0.922 |
| Depreciation | |||||
| Non-Cash Items | -0.72 | 0.789 | 0.379 | -0.649 | -0.108 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -9.54 | -3.84 | 3.87 | 4.18 | -2.47 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 3.89 | 3.25 | 10.5 | 9.13 | 5.51 |
| Capital Expenditures | -1.97 | -2.3 | -1.4 | -0.845 | -1.27 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0.151 | -3.38 | 0 | 0.654 | -4.6 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -1.81 | -5.67 | -1.4 | -0.191 | -5.87 |
| Financing Cash Flow Items | — | — | — | -0.277 | -0.259 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -17.5 | -6.74 | -7.21 | 1.48 | -5.48 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -15.3 | -9.16 | 1.93 | 10.4 | -5.81 |